Why the study?
Adherence to guideline-directed oral anticoagulation in AF improves outcomes, but limited data are available from China.
Does guideline-directed oral anticoagulation reduce all-cause death and thromboembolic events in elderly Chinese patients with atrial fibrillation?
Does guideline-directed oral anticoagulation reduce all-cause death and thromboembolic events in elderly Chinese patients with atrial fibrillation?
Guideline-directed oral anticoagulation is significantly underutilized in elderly Chinese patients with atrial fibrillation, and undertreatment is associated with increased mortality and thromboembolic events without reducing major bleeding.
No takes yet. Share an insight, caveat, or question.
May support closing OAC gaps in elderly Chinese AF patients; leaves open causal mortality and TE benefits.
Guo et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: